相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Epigenetic Changes in Cancer
Christine A. Iacobuzio-Donahue
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Large-Scale Profiling of Archival Lymph Nodes Reveals Pervasive Remodeling of the Follicular Lymphoma Methylome
J. Keith Killian et al.
CANCER RESEARCH (2009)
Epigenetic Profiles Distinguish Pleural Mesothelioma from Normal Pleura and Predict Lung Asbestos Burden and Clinical Outcome
Brock C. Christensen et al.
CANCER RESEARCH (2009)
Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer
James W. F. Catto et al.
CANCER RESEARCH (2009)
Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma
Carmen J. Marsit et al.
CARCINOGENESIS (2009)
Epigenetic gene regulation in stem cells and correlation to cancer
Lesley A. Mathews et al.
DIFFERENTIATION (2009)
BAMBI gene is epigenetically silenced in subset of high-grade bladder cancer
Sann Sanda Khin et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Epigenetic markers as promising prognosticators for bladder cancer
Young Kyoon Kim et al.
INTERNATIONAL JOURNAL OF UROLOGY (2009)
A Case-Control Study of Smoking and Bladder Cancer Risk: Emergent Patterns Over Time
Dalsu Baris et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Model-based clustering of DNA methylation array data: a recursive-partitioning algorithm for high-dimensional data arising as a mixture of beta distributions
E. Andres Houseman et al.
BMC BIOINFORMATICS (2008)
Identification of PMF1 Methylation in Association with Bladder Cancer Progression
Ainel Aleman et al.
CLINICAL CANCER RESEARCH (2008)
Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor
Eun-Jung Kim et al.
JOURNAL OF UROLOGY (2008)
Promoter Hypermethylation in Tumour Suppressor Genes Shows Association with Stage, Grade and Invasiveness of Bladder Cancer
Sonata Jarmalaite et al.
ONCOLOGY (2008)
Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)
Amanda F. Cashen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays
A. Aleman et al.
BRITISH JOURNAL OF CANCER (2008)
A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer
Jian Yu et al.
CLINICAL CANCER RESEARCH (2007)
Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer
Carmen J. Marsit et al.
CARCINOGENESIS (2007)
Promoter hypermethylation identifies progression risk in bladder cancer
David R. Yates et al.
CLINICAL CANCER RESEARCH (2007)
Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha
Kesavan Esuvaranathan et al.
CANCER (2007)
Epigenetic stem cell signature in cancer
Martin Widschwendter et al.
NATURE GENETICS (2007)
Feature-specific penalized latent class analysis for genomic data
E. Andres Houseman et al.
BIOMETRICS (2006)
Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors
Carmen J. Marsit et al.
CANCER RESEARCH (2006)
Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection
Mohammad Obaidul Hoque et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Chromatin signatures of pluripotent cell lines
V Azuara et al.
NATURE CELL BIOLOGY (2006)
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
BE Bernstein et al.
CELL (2006)
Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection
S Urakami et al.
CLINICAL CANCER RESEARCH (2006)
Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls
DR Yates et al.
ONCOGENE (2006)
High-throughput DNA methylation profiling using universal bead arrays
M Bibikova et al.
GENOME RESEARCH (2006)
TP53 alterations and patterns of carcinogen exposure in a US population-based study of bladder cancer
KT Kelsey et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer
CJ Marsit et al.
CANCER RESEARCH (2005)
Applications of beta-mixture models in bioinformatics
Y Ji et al.
BIOINFORMATICS (2005)
Keratins 8, 10, 13, and 17 are useful markers in the diagnosis of human cervix carcinomas
C Carrilho et al.
HUMAN PATHOLOGY (2004)
A population-based study of immunohistochemical detection of p53 alteration in bladder cancer
KT Kelsey et al.
BRITISH JOURNAL OF CANCER (2004)
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer
H Suzuki et al.
NATURE GENETICS (2004)
Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer
R Stoehr et al.
LABORATORY INVESTIGATION (2004)
Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genes
UG Sathyanarayana et al.
CANCER RESEARCH (2004)
A comparison of cluster analysis methods using DNA methylation data
KD Siegmund et al.
BIOINFORMATICS (2004)
The health economics of bladder cancer - A comprehensive review of the published literature
MF Botteman et al.
PHARMACOECONOMICS (2003)
Prognostic significance of p53 nuclear overexpression in patients of muscle invasive urinary bladder carcinoma treated with cystectomy
AK Hemal et al.
UROLOGIA INTERNATIONALIS (2003)
Model-based clustering, discriminant analysis, and density estimation
C Fraley et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2002)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
p53 nuclear accumulation is not associated with decreased disease-free survival in patients with node positive transitional cell carcinoma of the bladder
N Fleshner et al.
JOURNAL OF UROLOGY (2000)